Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)
Key facts
- Who runs it
- Ningbo Medical Center Lihuili Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 204 people, planned
- Started
- 1 May 2026
- Expected to end
- 31 Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Transcutaneous Electrical Acustimulation
- Record updated
- 15 May 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Age 18-75 years, irrespective of gender
- Typical heartburn symptoms for at least 3 months
- Heartburn on at least 2 days during the run-in diary period
- Endoscopically confirmed NERD (no esophageal erosions, Los Angeles grade N or M) within 12 months
- Willingness and ability to comply with all study procedures and to provide written informed consent
Who cannot take part
- Familiarity with acupuncture points and their functions (e.g., previous acupuncture experience or medical training)
- Any esophageal structural or mucosal disease (e.g., Barrett's esophagus, erosive esophagitis LA grade A-D, eosinophilic esophagitis, esophageal stricture, varices, malignancy, or prior chemical/thermal/radiation injury)
- Inability to discontinue prohibited medications (PPIs, P-CABs, H2RAs, prokinetics, or other GERD-directed therapies) except for protocol-defined rescue medication during the study
- Implanted electronic devices (e.g., pacemaker, defibrillator) or other implants susceptible to electrical stimulation
- History of or suspected diagnosis of functional heartburn or functional dyspepsia by Rome IV criteria
- Local skin disease or severe hypersensitivity at stimulation sites
- Systemic diseases affecting gastrointestinal motility (e.g., systemic sclerosis, dermatomyositis, systemic lupus erythematosus, amyloidosis), uncontrolled diabetes mellitus (fasting glucose ≥11.1 mmol/L or glycated hemoglobin ≥7.0%), severe cardiovascular disease, significant hepatic or renal dysfunction, or severe psychiatric disorders
- Presence of gastric or duodenal ulcers
- Pregnancy, breastfeeding, or planned pregnancy during the study period
- Participation in other interventional clinical trials within the past 3 months
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This multicenter study aims to evaluate whether Transcutaneous Electrical Acustimulation (TEA) is effective in treating Non-Erosive Gastroesophageal Reflux Disease (NERD). NERD is a common condition where patients experience symptoms like heartburn and regurgitation, but no visible damage can be seen in the esophagus during an endoscopy. TEA is a non-invasive treatment that uses a small device to deliver mild electrical stimulation through the skin on specific acupoints. This study will compare the effects of real TEA treatment with a sham (inactive) control. Participants will be randomly assigned to one of two groups: active TEA treatment or sham stimulation. Neither the participants nor the researchers evaluating the outcomes will know which treatment is being given. The main outcome is the improvement of reflux symptoms after 4 weeks of treatment. The results of this study may provide a new non-drug option for patients suffering from NERD.
The 2 groups in the trial
- ST36 TEA GroupTreatment being tested
Participants receive active transcutaneous electrical acustimulation (TEA) at the ST36 (Zusanli) acupoint unilaterally.
Treatment: Transcutaneous Electrical Acustimulation
- Sham TEA GroupSham treatment, for comparison
Participants receive sham transcutaneous electrical acustimulation (TEA) with electrodes placed unilaterally at the olecranon and 3-5 cm vertically down from the olecranon.
Treatment: Transcutaneous Electrical Acustimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD): A Multicenter, Randomized, Sham-Controlled Trial
- Criteria questions
- Built from NCT07572708, who can take part
- Record updated
- 15 May 2026